NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 172,956 Value ($000) $6,067 Avg Close $36.39 Range $28.19 - $42.00

Q3 2025

Shares 172,466 Value ($000) $4,905 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 178,846 Value ($000) $3,239 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 30,476 Value ($000) $624 Avg Close $22.23 Range $17.18 - $26.80

Q4 2024

Shares 30,476 Value ($000) $783 Avg Close $21.24 Range $15.51 - $27.29

Q3 2024

Shares 13,445 Value ($000) $223 Avg Close $17.30 Range $15.19 - $21.48

Q2 2024

Shares 13,445 Value ($000) $258 Avg Close $20.06 Range $16.62 - $24.79

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	172,956	$6,067	$36.39	$28.19 - $42.00
Q3 2025	172,466	$4,905	$23.97	$17.97 - $28.91
Q2 2025	178,846	$3,239	$18.24	$14.06 - $22.25
Q1 2025	30,476	$624	$22.23	$17.18 - $26.80
Q4 2024	30,476	$783	$21.24	$15.51 - $27.29
Q3 2024	13,445	$223	$17.30	$15.19 - $21.48
Q2 2024	13,445	$258	$20.06	$16.62 - $24.79